Despite the different doses of semaglutide and tirzepatide and timepoints studied, the results of SURMOUNT-5 and the Truveta Research study were consistent, namely that tirzepatide-based medications performed better than semaglutide-based medications: SURMOUNT-5 study : At 72 weeks, weight loss was 20.2% for Zepbound (tirzepatide AOM) compared to 13.7% for Wegovy (semaglutide AOM)
Int J Biochem Cell Biol 40:362382
Regional Analysis The market analysis covers key global regions, including South Asia, East Asia, Western Europe, North America, and India
It also improves physical performance, increases your endurance, and also helps you lose fat, due to the component of carnitine that stimulates fat loss
Most side effects resolve within one week as your body adapts
Albertsons and Walmart have both recently acknowledged that the sale of GLP-1 medications used both for weight loss and managing chronic conditions including diabetes have at least slightly helped sales for their pharmacy businesses